Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Comparison of Pegfilgrastim and Filgrastim to Prevent Neutropenic Fever during Consolidation with High Dose Cytarabine for Acute Myeloid Leukemia

Evan Field, Paolo F Caimi, MD, Brenda Cooper, MD, Jane Little, MD, Ehsan Malek, MD, Leland Metheny, MD, Marcos de Lima, MD, Pingfu Fu, Ben Tomlinson, MD

Blood (2018) 132 (Supplement 1): 1404.

https://doi.org/10.1182/blood-2018-99-118336

Published: 2018

Journal Articles

Cost-Effective Use of White Blood Cell Growth Factors in the Veterans Administration

Kevin Knopf, MD, William Hrureshky, Bryan Love, Leann Norris, Charles L. Bennett, MD PhD

Blood (2018) 132 (Supplement 1): 4761.

https://doi.org/10.1182/blood-2018-99-119724

Published: 2018

Journal Articles

Trends in Neutropenia-Related Hospitalization in Older Patients with Non-Hodgkin Lymphoma (NHL) Receiving Myelosuppressive Chemotherapy in the United States: 1995-2015

Shuling Li, PhD, Jiannong Liu, PhD, Haifeng Guo, MS, Prasad L Gawade, MBBS, PhD, Christopher Kim, PhD, Mark E. Bensink, PhD MSc, MD, David Chandler, PhD

Blood (2018) 132 (Supplement 1): 2308.

https://doi.org/10.1182/blood-2018-99-115213

Published: 2018

Journal Articles

A Study of Tbo-Filgrastim (Granix) to Disrupt the Bone Marrow Microenvironment in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Meagan Jacoby, MD, Reetom Bera, Theresa Fletcher, Mark A. Fiala, BS, Kathryn Trinkaus, PhD, John F. DiPersio, MD PhD, Keith E. Stockerl-Goldstein, MD, Mark A. Schroeder, MD, Daniel C. Link, MD, Ravi Vij, MBBS

Blood (2018) 132 (Supplement 1): 2146.

https://doi.org/10.1182/blood-2018-99-115603

Published: 2018

Journal Articles

A Phase 2, International, Multicenter, Prospective Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients with Solid Tumors Undergoing Chemotherapy

Noah Federman, Monica Desiree Dragomir, Zoryana Kizyma, Vladimir Lebedev, Jelena Roganovic, Peter Bias, Andreas Lammerich, Zipi Roth-Ben Arie, Linglong Zou, Anton Buchner

Blood (2017) 130 (Supplement 1): 2271.

https://doi.org/10.1182/blood.V130.Suppl_1.2271.2271

Published: 2017

Journal Articles

Immunogenicity Assessment of Tbo-Filgrastim in Cancer Patients Receiving Chemotherapy

Linglong Zou, Anton Buchner, Jodie Field, Steve Barash, Patrick Liu

Blood (2017) 130 (Supplement 1): 2274.

https://doi.org/10.1182/blood.V130.Suppl_1.2274.2274

Published: 2017

Journal Articles

Autologous Hematopoietic Progenitor Cells Mobilization with Combination of Pegfilgrastim and Plerixafor: Efficacy and Cost Assessment

Luciano J. Costa, MD PhD, Racquel Innis-Shelton, MD, Joscelyn Bowersock, MT, Ayman Saad, MD, Donna Salzman, MD, Antonio Di Stasi, MD, Nicole Watts, PharmD, Lawrence S. Lamb, Jr., PhD

Blood (2017) 130 (Supplement 1): 4708.

https://doi.org/10.1182/blood.V130.Suppl_1.4708.4708

Published: 2017

Journal Articles

Comparative Cost-Efficiency Analysis of Granulocyte Colony-Stimulating Factors for Use in Chemotherapy Patients in the United States

Elizabeth James, Holly Trautman, Erika Szabo, Boxiong Tang, MD PhD

Blood (2017) 130 (Supplement 1): 4667.

https://doi.org/10.1182/blood.V130.Suppl_1.4667.4667

Published: 2017

Journal Articles

Budget Impact Analysis of Switching Chemotherapy Patients Using Granulocyte Colony-Stimulating Factors (G-CSFs) from Pegfilgrastim to Short-Acting G-CSFs in the United States

Elizabeth James, Holly Trautman, Erika Szabo, Boxiong Tang, MD PhD

Blood (2017) 130 (Supplement 1): 4668.

https://doi.org/10.1182/blood.V130.Suppl_1.4668.4668

Published: 2017

Journal Articles

Use and Patterns of Supportive Care Among Patients Receiving Myelosuppressive Chemotherapy for Breast Cancer, Colorectal Cancer, Lung Cancer, or Non-Hodgkin's Lymphoma in US Clinical Practice

Derek Weycker, PhD, Amanda Silvia, BS, Kathryn Richert-Boe, MD MPH, Mark Bensink, PhD MS, James O. Brady, MD, Lois Lamerato, PhD, Heather Lipkovich, MPH, Ahmad Daniyal Siddiqui, MD, David Chandler, PhD MBA

Blood (2016) 128 (22): 5909.

https://doi.org/10.1182/blood.V128.22.5909.5909

Published: 2016

Journal Articles

Budget Impact Analysis of Treating Chemotherapy Patients with Patient-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Holly Trautman, Erika Szabo, Francesco Lo-Coco, Elizabeth James, Susan Gabriel, Jifang Zhou, Ashutosh Pathak, Boxiong Tang

Blood (2016) 128 (22): 4786.

https://doi.org/10.1182/blood.V128.22.4786.4786

Published: 2016

Journal Articles

Real-World Safety Experience for Short-Acting Recombinant Human Granulocyte Colony-Stimulating Factor

Camille N Abboud, Nicole Lang, Andreas Lammerich, Anton Buchner, Patrick Liu, Udo Mueller, Ashutosh Pathak

Blood (2016) 128 (22): 2504.

https://doi.org/10.1182/blood.V128.22.2504.2504

Published: 2016

Journal Articles

Budget Impact Analysis of Treating Chemotherapy Patients with Health Care Provider-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Holly Trautman, Erika Szabo, Francesco Lo-Coco, Elizabeth James, Susan Gabriel, Jifang Zhou, Ashutosh Pathak, Boxiong Tang

Blood (2016) 128 (22): 2407.

https://doi.org/10.1182/blood.V128.22.2407.2407

Published: 2016

Journal Articles

A Randomized Trial of Tbo-Filgrastim Versus Filgrastim for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma or Non-Hodgkin Lymphoma

Mark A Fiala, BS, CCRP, David Schwab, BA CCRP, Ravi Vij, MD MBA, Amanda F. Cashen, MD, Keith Stockerl-Goldstein, MD, Camille N. Abboud, MD

Blood (2015) 126 (23): 516.

https://doi.org/10.1182/blood.V126.23.516.516

Published: 2015

Journal Articles

A Retrospective Review of Engraftment Data for Tbo-Filgrastim Vs. Filgrastim in Patients Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation

Taylor Teschner, Stephen Lo, Dina Brauneis, Anthony C Shelton, Bhavesh Shah, John Mark Sloan, Cindy Varga, Karen Quillen, Vaishali Sanchorawala

Blood (2015) 126 (23): 5484.

https://doi.org/10.1182/blood.V126.23.5484.5484

Published: 2015

NARROW

Comparison of Pegfilgrastim and Filgrastim to Prevent Neutropenic Fever during Consolidation with High Dose Cytarabine for Acute Myeloid Leukemia

Cost-Effective Use of White Blood Cell Growth Factors in the Veterans Administration

Trends in Neutropenia-Related Hospitalization in Older Patients with Non-Hodgkin Lymphoma (NHL) Receiving Myelosuppressive Chemotherapy in the United States: 1995-2015

A Study of Tbo-Filgrastim (Granix) to Disrupt the Bone Marrow Microenvironment in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

A Phase 2, International, Multicenter, Prospective Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients with Solid Tumors Undergoing Chemotherapy

Immunogenicity Assessment of Tbo-Filgrastim in Cancer Patients Receiving Chemotherapy

Autologous Hematopoietic Progenitor Cells Mobilization with Combination of Pegfilgrastim and Plerixafor: Efficacy and Cost Assessment

Comparative Cost-Efficiency Analysis of Granulocyte Colony-Stimulating Factors for Use in Chemotherapy Patients in the United States

Budget Impact Analysis of Switching Chemotherapy Patients Using Granulocyte Colony-Stimulating Factors (G-CSFs) from Pegfilgrastim to Short-Acting G-CSFs in the United States

Use and Patterns of Supportive Care Among Patients Receiving Myelosuppressive Chemotherapy for Breast Cancer, Colorectal Cancer, Lung Cancer, or Non-Hodgkin's Lymphoma in US Clinical Practice

Budget Impact Analysis of Treating Chemotherapy Patients with Patient-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Real-World Safety Experience for Short-Acting Recombinant Human Granulocyte Colony-Stimulating Factor

Budget Impact Analysis of Treating Chemotherapy Patients with Health Care Provider-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

A Randomized Trial of Tbo-Filgrastim Versus Filgrastim for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma or Non-Hodgkin Lymphoma

A Retrospective Review of Engraftment Data for Tbo-Filgrastim Vs. Filgrastim in Patients Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only